Literature DB >> 12937134

Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.

Edward M Conway1, Femke Zwerts, Veerle Van Eygen, Astrid DeVriese, Nobuo Nagai, Wei Luo, Désiré Collen.   

Abstract

Approaches to regulating angiogenesis in the brain, which may diminish parenchymal damage after stroke, are lacking. Survivin, the inhibitor of apoptosis protein, is up-regulated in vitro in vascular endothelial cells by angiogenic factors, including vascular endothelial cell growth factor (VEGF). To evaluate the in vivo role of survivin in the brain in response to hypoxia/ischemia, we used a mouse model of stroke and show that 2 days after permanent middle cerebral artery occlusion, survivin is uniquely expressed by microvessels that form in the peri-infarct and infarct regions. The extent of vascularization of the infarct is dependent on expression of survivin, since vessel density is significantly reduced in mice with heterozygous deficiency of the survivin gene (survivin+/- mice), even though infarct sizes were not different. Hypoxia alone induces survivin expression in the brain, by cultured endothelial cells and by embryonic stem cells, but this response is at least partially independent of VEGF, hypoxia inducible factor 1alpha, or placental growth factor. Delineating the spatiotemporal pattern of expression of survivin after stroke, and the molecular mechanisms by which this is regulated, may provide novel approaches to therapeutically optimize angiogenesis in a variety of ischemic disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937134      PMCID: PMC1868240          DOI: 10.1016/S0002-9440(10)63453-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  70 in total

Review 1.  Mechanisms of angiogenesis in the brain.

Authors:  K H Plate
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

2.  Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells.

Authors:  R P Mason; P R Leeds; R F Jacob; C J Hough; K G Zhang; P E Mason; D M Chuang
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

3.  Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat.

Authors:  F Lennmyr; K A Ata; K Funa; Y Olsson; A Terént
Journal:  J Neuropathol Exp Neurol       Date:  1998-09       Impact factor: 3.685

4.  Placental growth factor is a survival factor for tumor endothelial cells and macrophages.

Authors:  Avner Adini; Tad Kornaga; Farshid Firoozbakht; Laura E Benjamin
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

5.  Gene promoter of apoptosis inhibitory protein IAP2: identification of enhancer elements and activation by severe hypoxia.

Authors:  Zheng Dong; Junichiro Nishiyama; Xiaolan Yi; Manjeri A Venkatachalam; Michael Denton; Sumin Gu; Senlin Li; Mei Qiang
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.

Authors:  Rial A Christensen; Koshi Fujikawa; Rebecca Madore; Peter Oettgen; Lyuba Varticovski
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

7.  Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.

Authors:  Rania Harfouche; Haroutioun M Hasséssian; Yang Guo; Valérie Faivre; Coimbatore B Srikant; George D Yancopoulos; Sabah N A Hussain
Journal:  Microvasc Res       Date:  2002-07       Impact factor: 3.514

8.  Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.

Authors:  Tsutomu Sasaki; M Beatriz S Lopes; Gerald R Hankins; Gregory A Helm
Journal:  Acta Neuropathol       Date:  2002-03-29       Impact factor: 17.088

9.  IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

Authors:  I Tamm; Y Wang; E Sausville; D A Scudiero; N Vigna; T Oltersdorf; J C Reed
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

10.  Control of apoptosis and mitotic spindle checkpoint by survivin.

Authors:  F Li; G Ambrosini; E Y Chu; J Plescia; S Tognin; P C Marchisio; D C Altieri
Journal:  Nature       Date:  1998-12-10       Impact factor: 49.962

View more
  38 in total

1.  Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Authors:  Qiuying Cheng; Xiang Ling; Andrew Haller; Takahito Nakahara; Kentaro Yamanaka; Aya Kita; Hiroshi Koutoku; Masahiro Takeuchi; Michael G Brattain; Fengzhi Li
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Lessons learned from cancer may help in the treatment of pulmonary hypertension.

Authors:  Serge Adnot
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.

Authors:  Hugo Caldas; Jason R Fangusaro; Daniel R Boué; Michael P Holloway; Rachel A Altura
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

5.  Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.

Authors:  Jing Tian; Sohrab Fratz; Yali Hou; Qing Lu; Agnes Görlach; John Hess; Christian Schreiber; Sanjeev A Datar; Peter Oishi; John Nechtman; Robert Podolsky; Jin-Xiong She; Jeffrey R Fineman; Stephen M Black
Journal:  Physiol Genomics       Date:  2010-10-26       Impact factor: 3.107

Review 6.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

7.  Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma.

Authors:  Hong Zhu; Xiao-Ping Chen; Wan-Guang Zhang; Shun-Feng Luo; Bi-Xiang Zhang
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

8.  The role of survivin in diagnosis, prognosis and treatment of breast cancer.

Authors:  Yong-Gang Lv; Fang Yu; Qing Yao; Jiang-Hao Chen; Ling Wang
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

9.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

10.  Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells.

Authors:  Qinhui Song; Xiaojin An; Dongmei Li; Neel R Sodha; Munir Boodhwani; Ye Tian; Frank W Sellke; Jian Li
Journal:  Microvasc Res       Date:  2009-08-27       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.